Needle exchange is not enough
- 1 July 1997
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 11 (8) , F59-F65
- https://doi.org/10.1097/00002030-199708000-00001
Abstract
To describe prevalence and incidence of HIV-1, hepatitis C virus (HCV) and risk behaviours in a prospective cohort of injecting drugs users (IDU). Vancouver, which introduced a needle exchange programme (NEP) in 1988, and currently exchanges over 2 million needles per year. IDU who had injected illicit drugs within the previous month were recruited through street outreach. At baseline and semi-annually, subjects underwent serology for HIV-1 and HCV, and questionnaires on demographics, behaviours and NEP attendance were completed. Logistic regression analysis was used to identify determinants of HIV prevalence. Of 1006 IDU, 65% were men, and either white (65%) or Native (27%). Prevalence rates of HIV-1 and HCV were 23 and 88%, respectively. The majority (92%) had attended Vancouver's NEP, which was the most important syringe source for 78%. Identical proportions of known HIV-positive and HIV-negative IDU reported lending used syringes (40%). Of HIV-negative IDU, 39% borrowed used needles within the previous 6 months. Relative to HIV-negative IDU, HIV-positive IDU were more likely to frequently inject cocaine (72 versus 62%; P < 0.001). Independent predictors of HIV-positive serostatus were low education, unstable housing, commercial sex, borrowing needles, being an established IDU, injecting with others, and frequent NEP attendance. Based on 24 seroconversions among 257 follow-up visits, estimated HIV incidence was 18.6 per 100 person-years (95% confidence interval, 11.1-26.0). Despite having the largest NEP in North America, Vancouver has been experiencing an ongoing HIV epidemic. Whereas NEP are crucial for sterile syringe provision, they should be considered one component of a comprehensive programme including counselling, support and education.Keywords
This publication has 17 references indexed in Scilit:
- HIV incidence among injecting drug users in New York City syringe-exchange programmesThe Lancet, 1996
- Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.American Journal of Public Health, 1995
- Risk Factors for Human Immunodeficiency Virus Seroconversion among Out-of-Treatment Drug Injectors in High and Low Seroprevalence CitiesAmerican Journal of Epidemiology, 1995
- Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MdArchives of internal medicine (1960), 1995
- Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993AIDS, 1995
- Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.American Journal of Public Health, 1994
- Age and DepressionJournal of Health and Social Behavior, 1992
- New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1American Journal of Epidemiology, 1991
- ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLANDAmerican Journal of Epidemiology, 1990
- Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS.American Journal of Public Health, 1989